Low Dose Atropine Eye Drops in Myopic Egyptian Children

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

December 30, 2025

Study Completion Date

March 30, 2026

Conditions

Myopia ProgressionAxial Length, EyeSclera Thickness

Interventions

DRUG

low dose atropine eye drops

Atropine is a nonselective muscarinic antagonist used for myopia control in previous studies.

DRUG

Placebo

placebo

Trial Locations (1)

Ain shams university, Cairo

All Listed Sponsors

lead

Ain Shams University

OTHER

NCT06265454 - Low Dose Atropine Eye Drops in Myopic Egyptian Children | Biotech Hunter | Biotech Hunter